Sandrine Carle Named Deputy CEO at Spineway Group

The Spineway Group has appointed Sandrine Carle as deputy CEO, 16 months after joining the company with itse Spine Innovations acquisition (July 2022).

Carle was instrumental in integrating Spine Innovations (where she served as CEO) into the Spineway Group. Working with Spineway CEO Stéphane Le Roux, Carle will be responsible for conducting the company’s overall roadmap, particularly the business development plan aimed at returning to positive operating income as well as all R&D projects.

‘I am delighted that Sandrine is joining me as deputy chief executive officer,” Le Roux said. “I am confident that her leadership, strategic acumen, and deep understanding of the market will help shape our future. She will strengthen our management team. Sandrine will also lead the Group’s development plan, while maintaining our commitment to our core values of quality and innovation. She will work closely with me, our management team, and all our employees to achieve our aim of becoming an innovative player in France and internationally.”

Carle worked for more for more than 20 years in orthopedic surgery, specifically in Medtronic’s spinal surgery sector (Europe0, Kyphon (United States), and Vexim (France). She held marketing and management positions in France and the United States before becoming Spine Innovations CEO in 2020. Carle created the firm following a spinoff, leading the recruitment and management of roughly 15 employees. She also set up the functional and operational organization of the team and obtained the company’s Notified Body certification.

Carle earned a degree in biomedical engineering and an executive MBA at HEC in Paris. 

Spineway designs, manufactures, and markets spinal implants and instruments. It has an international network of more than 50 independent distributors and 90% of its revenue is derived from exports.